Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions

Inflammatory Bowel Disease

Interventions

DRUG

Monofer (iron isomaltoside 1000)

1000 mg iron isomaltoside administered as a infusion over 15 minutes

DRUG

Monofer

500 mg iron isomaltoside 1000 given as bolus injection over 2 minutes